Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 342.00 | 274.75 | 1.2448 | 1.5974 |
| BT-20 | Erlotinib | 1 | uM | 9 | 312.50 | 153.73 | 364.00 | 274.75 | 1.3248 | 1.7980 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 312.50 | 153.73 | 350.00 | 274.75 | 1.2739 | 1.6701 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 266.00 | 274.75 | 0.9682 | 0.9242 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 312.50 | 153.73 | 117.00 | 274.75 | 0.4258 | -0.2781 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 242.00 | 274.75 | 0.8808 | 0.7188 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 276.00 | 274.75 | 1.0045 | 1.0109 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 312.50 | 153.73 | 230.00 | 274.75 | 0.8371 | 0.6176 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 306.00 | 274.75 | 1.1137 | 1.2744 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 280.00 | 274.75 | 1.0191 | 1.0457 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 166.00 | 274.75 | 0.6042 | 0.0960 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 330.00 | 274.75 | 1.2011 | 1.4890 |
| BT-20 | Erlotinib | 10 | uM | 9 | 312.50 | 153.73 | 255.00 | 274.75 | 0.9281 | 0.8296 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 415.00 | 274.75 | 1.5105 | 2.2721 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 312.50 | 153.73 | 323.00 | 274.75 | 1.1756 | 1.4261 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 312.50 | 153.73 | 416.00 | 274.75 | 1.5141 | 2.2815 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 312.50 | 153.73 | 288.00 | 274.75 | 1.0482 | 1.1157 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 312.50 | 153.73 | 301.00 | 274.75 | 1.0955 | 1.2301 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 312.50 | 153.73 | 134.00 | 274.75 | 0.4877 | -0.1512 |
| BT-20 | Linsitinib | 10 | uM | 9 | 312.50 | 153.73 | 319.00 | 274.75 | 1.1611 | 1.3903 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 341.00 | 274.75 | 1.2411 | 1.5883 | |
| BT-20 | Lapatinib | 1 | uM | 9 | 312.50 | 153.73 | 239.00 | 274.75 | 0.8699 | 0.6934 |
| BT-20 | Lapatinib | 10 | uM | 9 | 312.50 | 153.73 | 111.00 | 274.75 | 0.4040 | -0.3221 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 378.00 | 274.75 | 1.3758 | 1.9270 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 312.50 | 153.73 | 333.00 | 274.75 | 1.2120 | 1.5160 |